Poster – Integrated Tumor-informed and Tumor-agnostic ctDNA Molecular Residual Disease (MRD) Assessment with Imaging in Early Breast Cancer.

Disclaimer Notice:
Copies of this poster obtained through QR, AR and/or text key codes are for personal use only and may not be reproduced without written permission of the authors.